AstraZeneca to Build $360 Million Manufacturing Plant in Dublin
21 Setembro 2021 - 3:38AM
Dow Jones News
By Jaime Llinares Taboada
AstraZeneca PLC said Tuesday that it will invest $360 million in
a manufacturing facility in Ireland.
The pharmaceutical company said it is planning to build an
active pharmaceutical ingredient-manufacturing facility for small
molecules near Dublin to ensure that its supply network is fit for
future growth.
The plant will allow for late-stage development and early
commercial supply, AstraZeneca said. It will create 100 direct jobs
and further indirect jobs.
Write to Jaime Llinares Taboada at jaime.llinares@wsj.com;
@JaimeLlinaresT
(END) Dow Jones Newswires
September 21, 2021 02:23 ET (06:23 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
AstraZeneca (NASDAQ:AZN)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
AstraZeneca (NASDAQ:AZN)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024
